Track Galecto, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Galecto, Inc. GLTO · Stock Open Galecto, Inc. in new tab

21.58 USD
EPS
-12.11
P/B
5.71
ROE
-109.49
Beta
1.57
Target Price
46.75 USD
Loading chart...
Key Metrics
EPS-12.11
Book Value5.02
Price to Book5.71
Debt/Equity0.90
% Insiders1.464%
Estimates
Forward P/E-30.20
Forward EPS-0.95
Target Mean Price46.75

DCF valuation

Model fair value for Galecto, Inc. (GLTO)
Result
Sign in to run the valuation for GLTO.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–
Analyst price targets
mean target 46.75 USD (low 40.00, high 57.00)
Low 40.00
Mean 46.75
High 57.00
Price 21.58
Published broker research as supplied by our market data feed, named by firm and dated; it does not identify individual analysts. Targets carry their last refresh date; rating changes can be a few days behind.

Galecto, Inc. Logo Galecto, Inc. Analysis (GLTO)

Denmark Health Care Official Website Stock

Is Galecto, Inc. a good investment? Galecto, Inc. (GLTO) is currently trading at 21.58 USD. Market analysts have a consensus price target of 46.75 USD. This suggests a potential upside from current levels.

Investor FAQ

Does Galecto, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Galecto, Inc.?

Galecto, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

Damora Therapeutics, Inc., a clinical-stage biotechnology company, develops molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. It develops GB3226, a preclinical small molecule dual inhibitor of ENL-YEATS and FLT3 and GB1211, an oral small molecule inhibitor of galectin-3 to treat multiple types of oncology and liver disease indications. The company was founded in 2011 and is headquartered in Copenhagen, Denmark.

Exchange Ticker
NMS (United States) GLTO
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
Aug. 30, 2024 1:25
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion